Zobrazeno 1 - 10
of 188
pro vyhledávání: '"Brouwer KL"'
Publikováno v:
Journal of Clinical Pharmacology; May2002, Vol. 42 Issue 5, p569-576, 8p
Autor:
McLaughlin JE; University of North Carolina, Eshelman School of Pharmacy, Chapel Hill, North Carolina jacqui_mclaughlin@unc.edu., Tropsha A; University of North Carolina, Eshelman School of Pharmacy, Chapel Hill, North Carolina., Nicolazzo JA; Monash University, Faculty of Pharmacy and Pharmaceutical Sciences, Melbourne, Australia., Crescenzi A; University of North Carolina, Eshelman School of Pharmacy, Chapel Hill, North Carolina., Brouwer KL; University of North Carolina, Eshelman School of Pharmacy, Chapel Hill, North Carolina.
Publikováno v:
American journal of pharmaceutical education [Am J Pharm Educ] 2022 Mar; Vol. 86 (3), pp. 8670. Date of Electronic Publication: 2021 Jul 22.
Autor:
Woodhead JL; DILIsym Services, Inc, Research Triangle Park, North Carolina., Brock WJ; Otsuka Pharmaceutical Development & Commercialization, Brock Scientific Consulting, Montgomery Village, Rockville, Maryland., Roth SE; Otsuka Pharmaceutical Development & Commercialization, Rockville, Maryland., Shoaf SE; Otsuka Pharmaceutical Development & Commercialization, Rockville, Maryland., Brouwer KL; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Church R; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; UNC Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina., Grammatopoulos TN; BioEnergetics LLC, Boston, Massachusetts., Stiles L; BioEnergetics LLC, Boston, Massachusetts., Siler SQ; DILIsym Services, Inc, Research Triangle Park, North Carolina., Howell BA; DILIsym Services, Inc, Research Triangle Park, North Carolina., Mosedale M; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; UNC Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina., Watkins PB; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; UNC Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina., Shoda LK; DILIsym Services, Inc, Research Triangle Park, North Carolina; lshoda@dilisym.com.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2017 Jan; Vol. 155 (1), pp. 61-74. Date of Electronic Publication: 2016 Sep 21.
Autor:
Autmizguine J; From the *Department of Pharmacology, University of Montreal, Montreal, Quebec, Canada; †Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina; and ‡Eshelman School of Pharmacy, The University of North Carolina, Chapel Hill, North Carolina., Hornik CP, Benjamin DK Jr, Brouwer KL, Hupp SR, Cohen-Wolkowiez M, Watt KM
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2016 Nov; Vol. 35 (11), pp. 1204-1210.
Autor:
Wells MA; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Vendrov KC; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Edin ML; Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States., Ferslew BC; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Zha W; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Nguyen BK; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Church RJ; University of North Carolina Institute for Drug Safety Sciences, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Lih FB; Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States., DeGraff LM; Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States., Brouwer KL; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Barritt AS 4th; Division of Gastroenterology and Hepatology, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Zeldin DC; Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States., Lee CR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Electronic address: craig_lee@unc.edu.
Publikováno v:
Prostaglandins & other lipid mediators [Prostaglandins Other Lipid Mediat] 2016 Sep; Vol. 125, pp. 19-29. Date of Electronic Publication: 2016 Jul 09.
Autor:
Guo C; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (C.G., K.Y., K.L.R.B.); and Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C.)., Yang K; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (C.G., K.Y., K.L.R.B.); and Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C.)., Brouwer KR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (C.G., K.Y., K.L.R.B.); and Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C.)., St Claire RL 3rd; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (C.G., K.Y., K.L.R.B.); and Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C.)., Brouwer KL; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (C.G., K.Y., K.L.R.B.); and Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C.) kbrouwer@email.unc.edu.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2016 Aug; Vol. 358 (2), pp. 324-33. Date of Electronic Publication: 2016 May 27.
Autor:
Lan K; Key laboratory of Drug Targeting and Drug Delivery System, Ministry of Education, West China School of Pharmacy, Sichuan University , Chengdu 610041, China.; Metabolomics Shared Resource, University of Hawaii Cancer Center , Honolulu, Hawaii 96813, United States., Su M; Metabolomics Shared Resource, University of Hawaii Cancer Center , Honolulu, Hawaii 96813, United States., Xie G; Metabolomics Shared Resource, University of Hawaii Cancer Center , Honolulu, Hawaii 96813, United States., Ferslew BC; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina 27599-7569, United States., Brouwer KL; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina 27599-7569, United States., Rajani C; Metabolomics Shared Resource, University of Hawaii Cancer Center , Honolulu, Hawaii 96813, United States., Liu C; State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research , Tianjin 300193, China., Jia W; Metabolomics Shared Resource, University of Hawaii Cancer Center , Honolulu, Hawaii 96813, United States.
Publikováno v:
Analytical chemistry [Anal Chem] 2016 Jul 19; Vol. 88 (14), pp. 7041-8. Date of Electronic Publication: 2016 Jun 30.
Autor:
Lu Y; University of North Carolina at Chapel Hill;, Slizgi JR; University of North Carolina at Chapel Hill;, Brouwer KR; Qualyst Transporter Solutions;, Claire RL; Qualyst Transporter Solutions;, Freeman KM; Qualyst Transporter Solutions;, Pan M; Otsuka PDC., Brock WJ; Otsuka PDC., Brouwer KL; University of North Carolina at Chapel Hill; kbrouwer@unc.edu.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2016 Jun; Vol. 44 (6). Date of Electronic Publication: 2016 Mar 24.
Autor:
Slizgi JR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599; kbrouwer@unc.edu., Lu Y; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599;, Brouwer KR; Qualyst Transporter Solutions, Durham, North Carolina 27713; and., St Claire RL; Qualyst Transporter Solutions, Durham, North Carolina 27713; and., Freeman KM; Qualyst Transporter Solutions, Durham, North Carolina 27713; and., Pan M; Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, Maryland 20850., Brock WJ; Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, Maryland 20850., Brouwer KL; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599; kbrouwer@unc.edu.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2016 Jan; Vol. 149 (1), pp. 237-50. Date of Electronic Publication: 2015 Oct 26.
Autor:
Ferslew BC; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Kerr Hall, CB #7569, Chapel Hill, NC, 27599, USA. bferslew@theravance.com.; Clinical Pharmacology and Drug Metabolism and Pharmacokinetics, Theravance Biopharma US, Inc., 901 Gateway Blvd, South San Francisco, CA, 94080, USA. bferslew@theravance.com., Xie G; Metabolomics Shared Resource, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA. GXie@cc.hawaii.edu., Johnston CK; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Kerr Hall, CB #7569, Chapel Hill, NC, 27599, USA. curtis.k.johnston@gmail.com., Su M; Metabolomics Shared Resource, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA. MSu@cc.hawaii.edu., Stewart PW; Department of Biostatistics, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 3105G McGavran-Greenberg Hall, Chapel Hill, NC, 27599, USA. Paul_Stewart@unc.edu., Jia W; Metabolomics Shared Resource, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA. WJia@cc.hawaii.edu., Brouwer KL; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Kerr Hall, CB #7569, Chapel Hill, NC, 27599, USA. kbrouwer@unc.edu., Barritt AS 4th; Division of Gastroenterology and Hepatology, UNC School of Medicine, University of North Carolina at Chapel Hill, 8004 Burnett Womack, CB #7584, Chapel Hill, NC, 27599-7584, USA. sid_barritt@med.unc.edu.
Publikováno v:
Digestive diseases and sciences [Dig Dis Sci] 2015 Nov; Vol. 60 (11), pp. 3318-28. Date of Electronic Publication: 2015 Jul 03.